NZ186355A - Hydroxy acids and pharmaceutical compositions - Google Patents

Hydroxy acids and pharmaceutical compositions

Info

Publication number
NZ186355A
NZ186355A NZ186355A NZ18635578A NZ186355A NZ 186355 A NZ186355 A NZ 186355A NZ 186355 A NZ186355 A NZ 186355A NZ 18635578 A NZ18635578 A NZ 18635578A NZ 186355 A NZ186355 A NZ 186355A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
hydroxy acids
hydroxy
acids
pharmaceutical
Prior art date
Application number
NZ186355A
Inventor
Cj Strawson
Dc Aldridge
Gc Crawley
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of NZ186355A publication Critical patent/NZ186355A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/34—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings containing more than one carboxyl group

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ186355A 1977-02-16 1978-01-30 Hydroxy acids and pharmaceutical compositions NZ186355A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB644977 1977-02-16
GB644877 1977-02-16
GB1977277 1977-05-11

Publications (1)

Publication Number Publication Date
NZ186355A true NZ186355A (en) 1979-10-25

Family

ID=27254837

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ186355A NZ186355A (en) 1977-02-16 1978-01-30 Hydroxy acids and pharmaceutical compositions

Country Status (9)

Country Link
JP (1) JPS53103467A (en)
DE (1) DE2804084A1 (en)
DK (1) DK70178A (en)
FI (1) FI780487A (en)
FR (1) FR2381041A1 (en)
IT (1) IT1095422B (en)
NL (1) NL7801434A (en)
NZ (1) NZ186355A (en)
SE (1) SE7801755L (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489412A (en) * 1974-09-27 1977-10-19 Ici Ltd Furo(3,4-b)furan derivatives and their use in pharmaceutical compositions

Also Published As

Publication number Publication date
FI780487A (en) 1978-08-17
NL7801434A (en) 1978-08-18
IT1095422B (en) 1985-08-10
SE7801755L (en) 1978-08-17
DE2804084A1 (en) 1978-08-17
FR2381041A1 (en) 1978-09-15
JPS53103467A (en) 1978-09-08
DK70178A (en) 1978-08-17
IT7820334A0 (en) 1978-02-16

Similar Documents

Publication Publication Date Title
NZ188872A (en) 9-(-heteroarylamino-alkylamino)-erthromycins and pharmaceutical compositions
NZ189296A (en) N-substituted-omega-aminoalkanoyl-omega-aminoalkanoic acids and pharmaceutical compositions
NZ188170A (en) Propenylamines and pharmaceutical compositions
NZ187235A (en) Aminoalkylbenzene derivatives and pharmaceutical compositions
NZ187794A (en) 1-acyl-2-cynanoaziridines and immunestimulating pharmaceutical compositions
NZ187611A (en) Lipopeptides and pharmaceutical compositions
JPS53139729A (en) Pharmaceutical composition and method
NZ187272A (en) Alkylenediamine derivatives and pharmaceutical compositions
NZ189246A (en) 4-spectinomycylamine its salts and pharmaceutical compositions
DE2862107D1 (en) Glucosamine-peptide derivatives and their pharmaceutical compositions
NZ188531A (en) W-mercapto-propionamides and pharmaceutical compositions
NZ188772A (en) Pyrazinobenzoxazepine derivatives and pharmaceutical compositions
NZ188798A (en) 2-iminoimidazolidine derivatives and pharmaceutical compositions
NZ190521A (en) Phenylamino-thiophenacetic acids and pharmaceutical compositions
NZ187085A (en) 3-pyridazione derivatives and pharmaceutical compositions
NZ187571A (en) N-glucofuranosid-6-yl-n-nitroso-urea derivatives and pharmaceutical compositions
ZA784470B (en) Pharmaceutical compositions including antithormbotic compositions
JPS5470255A (en) Nnbenzylanthracycline and pharmaceutical composition
NZ188101A (en) N-substituted-2-aminobenzoic acid derivatives and pharmaceutical compositions
NZ187431A (en) 19-oxygenated pregnane derivatives and pharmaceutical compositions
IL54220A0 (en) Pharmaceutical compositions comprising trans-broparestrol
NZ186198A (en) N2-aryl (or aralkyl) sulphonyl-l-argininamide and pharmaceutical compositions
NZ187195A (en) Benzenesulphonyl-urea derivatives and pharmaceutical compositions
NZ186397A (en) Pharmaceutical compositions 8h-indeno (2,1-b)thiophen-2-oxaminic acids and esters and
NZ187337A (en) 5-phenyl-1h-3-benzazepines and pharmaceutical compositions